Nome Químico: (6R,8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-17-(((fluoromethyl)thio)carbonyl)-6,11-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
Sorrisos: O=C1C=C[C@@]2(C)C([C@H](O)C[C@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@]4(OC(CC)=O)C(SCF)=O)=C1
Inchi: InChI=1S/C25H32F2O6S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(29)17-9-14(28)6-7-22(17,3)24(16,27)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,29-30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1
Characterisation of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC–NMR spectroscopy and HPLC–MS
Nisha Mistry a , Ismail M. Ismail b , Marco S. Smith c , Jeremy K. Nicholson d , John C. Lindon
Journal of Pharmaceutical and Biomedical Analysis 16 (1997) 697–705